Cargando…
Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
Dupilumab associated head and neck dermatitis is incompletely understood. This prospective multicentre prospective study identified baseline Malassezia‐specific IgE as associated with the development of Dupilumab associated head and neck dermatitis.[Image: see text]
Autores principales: | Kozera, Emily, Stewart, Thomas, Gill, Kyra, De La Vega, Mae Anne, Frew, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322676/ https://www.ncbi.nlm.nih.gov/pubmed/35041759 http://dx.doi.org/10.1111/bjd.21019 |
Ejemplares similares
-
Anti-Malassezia-Specific IgE Antibodies Production in Japanese Patients with Head and Neck Atopic Dermatitis: Relationship between the Level of Specific IgE Antibody and the Colonization Frequency of Cutaneous Malassezia Species and Clinical Severity
por: Zhang, Enshi, et al.
Publicado: (2011) -
Serum IgE reduction and paradoxical eosinophilia associated with allergic conjunctivitis after dupilumab therapy
por: Kimura, Ayaka, et al.
Publicado: (2021) -
Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab
por: Nihal, Aman, et al.
Publicado: (2022) -
The Role of Malassezia spp. in Atopic Dermatitis
por: Glatz, Martin, et al.
Publicado: (2015) -
Dupilumab modulates specific IgE mite responses at the molecular level in severe T2-high atopic dermatitis: A real-world experience
por: González-Pérez, Ruperto, et al.
Publicado: (2022)